DNA/RNA Sample Extraction and Isolation Market By Product (Consumables, Instruments) , By Application (PCR, NGS, Cloning, Microarray, Blotting Techniques, Other Applications) By End User (Clinical Diagnostic and Forensic Laboratories, Research Academics and Institutions, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
DNA/RNA Sample Extraction and Isolation Market
The DNA/RNA sample extraction and isolation market was valued at $2.8 billion in 2023 and is projected to reach $5.5 billion by 2033, growing at a CAGR of 6.9% from 2024 to 2033.
DNA/RNA sample extraction and isolation is a biomolecular technique that involves procuring nucleic acid from biological samples. Preserving the integrity and functionality of DNA/RNA is a critical requisite of this technique. The genome is extracted from diverse samples, including saliva, blood, cultured cells, tissue biopsies, and environmental samples such as soil & water. Efficient extraction and storage of DNA/RNA is crucial as the sample is utilized further for genetic analysis, sequencing, cloning, or diagnostics.
Advancements in genomic technology have fueled the demand for high-quality DNA and RNA, propelling the growth of the market. In addition, rise in investments in R&D activities to boost their capacity and efficiency drives the growth of the market considerably. Examination of novel adsorbents with higher nucleic acid-capturing ability as compared to conventional procedures such as phenol-chloroform and ethanol precipitation is a notable trend in the DNA/RNA sample extraction and isolation market. For instance, several studies have demonstrated the remarkable DNA-capturing capabilities of plant fiber-based adsorbents.
However, high costs of procuring the extraction & isolation kits deter several small-scale laboratories and institutions from investing in them, restraining the development of the market. Furthermore, stringent regulatory & approval processes associated with the introduction of novel DNA/RNA sample extraction and isolation solutions hamper the market growth. On the contrary, rise in the popularity of biobanks to store biological specimens and genomic samples is anticipated to present lucrative opportunities for the market. For instance, scientists at Harvard and the Broad Institute of MIT, along with colleagues at the University of Michigan established the “Global Biobank Meta-analysis Initiative” to unite international biobanks to strengthen the studies of genetic data. Therefore, the DNA/RNA sample extraction and isolation market is projected to witness new avenues for the assembly of a widespread collection of genomic data in biobanks.
Segment Review
The DNA/RNA sample extraction and isolation market is segmented into product, application, end user, and region. On the basis of product, the market is bifurcated into consumables and instruments. Depending on application, it is divided into PCR, NGS, cloning, microarray, blotting techniques, and other applications. As per end user, it is classified into clinical diagnostic & forensic laboratories, research academics & institutions, pharmaceutical & biotechnology companies, contract research organizations, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of product, the consumables segment acquires a high stake in the market.
Depending on application, the PCR segment dominates the market share.
As per end user, the research academics & institutions segment accounts for a high share of the market.
Region wise, North America is the highest revenue generator in the market.
Competition Analysis
The major players in the global DNA/RNA sample extraction and isolation market include Thermo Fisher Scientific Inc., QIAGEN, Minerva Biolabs GmbH, ACON Laboratories, Inc., Bio-Rad Laboratories, Inc., Abnova Corporation, Merck KGaA, Promega Corporation, F. Hoffmann-La Roche Ltd, and Tecan Trading AG. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Key Market Segments
By Product
Consumables
Instruments
By Application
PCR
NGS
Cloning
Microarray
Blotting Techniques
Other Applications
By End User
Clinical Diagnostic and Forensic Laboratories
Research Academics and Institutions
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Thermo Fisher Scientific Inc.
QIAGEN
Minerva Biolabs GmbH
ACON Laboratories, Inc.
Bio-Rad Laboratories, Inc.
Abnova Corporation
Merck KGaA
Promega Corporation
F. Hoffmann-La Roche Ltd
Tecan Trading AG
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
- 4.2. Consumables
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Instruments
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5: DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. PCR
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. NGS
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Cloning
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Microarray
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- 5.6. Blotting Techniques
- 5.6.1. Key Market Trends, Growth Factors and Opportunities
- 5.6.2. Market Size and Forecast, By Region
- 5.6.3. Market Share Analysis, By Country
- 5.7. Other Applications
- 5.7.1. Key Market Trends, Growth Factors and Opportunities
- 5.7.2. Market Size and Forecast, By Region
- 5.7.3. Market Share Analysis, By Country
- CHAPTER 6: DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Clinical Diagnostic And Forensic Laboratories
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Research Academics And Institutions
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Pharmaceutical And Biotechnology Companies
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5. Contract Research Organizations
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
- 6.6. Others
- 6.6.1. Key Market Trends, Growth Factors and Opportunities
- 6.6.2. Market Size and Forecast, By Region
- 6.6.3. Market Share Analysis, By Country
- CHAPTER 7: DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Product
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. DNA/RNA Sample Extraction and Isolation Market
- 7.2.6.1. Market Size and Forecast, By Product
- 7.2.6.2. Market Size and Forecast, By Application
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada DNA/RNA Sample Extraction and Isolation Market
- 7.2.7.1. Market Size and Forecast, By Product
- 7.2.7.2. Market Size and Forecast, By Application
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico DNA/RNA Sample Extraction and Isolation Market
- 7.2.8.1. Market Size and Forecast, By Product
- 7.2.8.2. Market Size and Forecast, By Application
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Product
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany DNA/RNA Sample Extraction and Isolation Market
- 7.3.6.1. Market Size and Forecast, By Product
- 7.3.6.2. Market Size and Forecast, By Application
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France DNA/RNA Sample Extraction and Isolation Market
- 7.3.7.1. Market Size and Forecast, By Product
- 7.3.7.2. Market Size and Forecast, By Application
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. UK DNA/RNA Sample Extraction and Isolation Market
- 7.3.8.1. Market Size and Forecast, By Product
- 7.3.8.2. Market Size and Forecast, By Application
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy DNA/RNA Sample Extraction and Isolation Market
- 7.3.9.1. Market Size and Forecast, By Product
- 7.3.9.2. Market Size and Forecast, By Application
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain DNA/RNA Sample Extraction and Isolation Market
- 7.3.10.1. Market Size and Forecast, By Product
- 7.3.10.2. Market Size and Forecast, By Application
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe DNA/RNA Sample Extraction and Isolation Market
- 7.3.11.1. Market Size and Forecast, By Product
- 7.3.11.2. Market Size and Forecast, By Application
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Product
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan DNA/RNA Sample Extraction and Isolation Market
- 7.4.6.1. Market Size and Forecast, By Product
- 7.4.6.2. Market Size and Forecast, By Application
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China DNA/RNA Sample Extraction and Isolation Market
- 7.4.7.1. Market Size and Forecast, By Product
- 7.4.7.2. Market Size and Forecast, By Application
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India DNA/RNA Sample Extraction and Isolation Market
- 7.4.8.1. Market Size and Forecast, By Product
- 7.4.8.2. Market Size and Forecast, By Application
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. Australia DNA/RNA Sample Extraction and Isolation Market
- 7.4.9.1. Market Size and Forecast, By Product
- 7.4.9.2. Market Size and Forecast, By Application
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea DNA/RNA Sample Extraction and Isolation Market
- 7.4.10.1. Market Size and Forecast, By Product
- 7.4.10.2. Market Size and Forecast, By Application
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific DNA/RNA Sample Extraction and Isolation Market
- 7.4.11.1. Market Size and Forecast, By Product
- 7.4.11.2. Market Size and Forecast, By Application
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Product
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil DNA/RNA Sample Extraction and Isolation Market
- 7.5.6.1. Market Size and Forecast, By Product
- 7.5.6.2. Market Size and Forecast, By Application
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia DNA/RNA Sample Extraction and Isolation Market
- 7.5.7.1. Market Size and Forecast, By Product
- 7.5.7.2. Market Size and Forecast, By Application
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. South Africa DNA/RNA Sample Extraction and Isolation Market
- 7.5.8.1. Market Size and Forecast, By Product
- 7.5.8.2. Market Size and Forecast, By Application
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA DNA/RNA Sample Extraction and Isolation Market
- 7.5.9.1. Market Size and Forecast, By Product
- 7.5.9.2. Market Size and Forecast, By Application
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Thermo Fisher Scientific Inc.
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. QIAGEN
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Minerva Biolabs GmbH
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. ACON Laboratories, Inc.
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Bio-Rad Laboratories, Inc.
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Abnova Corporation
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Merck KGaA
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Promega Corporation
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. F. Hoffmann-La Roche Ltd
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Tecan Trading AG
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 2. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR CONSUMABLES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR INSTRUMENTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. GLOBAL DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 5. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR PCR, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR NGS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR CLONING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR MICROARRAY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR BLOTTING TECHNIQUES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. GLOBAL DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 12. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR CLINICAL DIAGNOSTIC AND FORENSIC LABORATORIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR RESEARCH ACADEMICS AND INSTITUTIONS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 16. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 17. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 18. NORTH AMERICA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 19. NORTH AMERICA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 20. NORTH AMERICA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 21. NORTH AMERICA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 22. U.S. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 23. U.S. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 24. U.S. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 25. CANADA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 26. CANADA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 27. CANADA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 28. MEXICO DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 29. MEXICO DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 30. MEXICO DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 31. EUROPE DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 32. EUROPE DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 33. EUROPE DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 34. EUROPE DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 35. GERMANY DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 36. GERMANY DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 37. GERMANY DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 38. FRANCE DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 39. FRANCE DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 40. FRANCE DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 41. UK DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 42. UK DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 43. UK DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 44. ITALY DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 45. ITALY DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 46. ITALY DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 47. SPAIN DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 48. SPAIN DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 49. SPAIN DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 50. REST OF EUROPE DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 51. REST OF EUROPE DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 52. REST OF EUROPE DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 53. ASIA-PACIFIC DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 54. ASIA-PACIFIC DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 55. ASIA-PACIFIC DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 56. ASIA-PACIFIC DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 57. JAPAN DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 58. JAPAN DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 59. JAPAN DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 60. CHINA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 61. CHINA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 62. CHINA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 63. INDIA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 64. INDIA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 65. INDIA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 66. AUSTRALIA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 67. AUSTRALIA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 68. AUSTRALIA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 69. SOUTH KOREA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 70. SOUTH KOREA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 71. SOUTH KOREA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 72. REST OF ASIA-PACIFIC DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 73. REST OF ASIA-PACIFIC DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 74. REST OF ASIA-PACIFIC DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 75. LAMEA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 76. LAMEA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 77. LAMEA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 78. LAMEA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 79. BRAZIL DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 80. BRAZIL DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 81. BRAZIL DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 82. SAUDI ARABIA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 83. SAUDI ARABIA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 84. SAUDI ARABIA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 85. SOUTH AFRICA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 86. SOUTH AFRICA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 87. SOUTH AFRICA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 88. REST OF LAMEA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 89. REST OF LAMEA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 90. REST OF LAMEA DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 91. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
- TABLE 92. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
- TABLE 93. THERMO FISHER SCIENTIFIC INC. : OPERATING SEGMENTS
- TABLE 94. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
- TABLE 95. THERMO FISHER SCIENTIFIC INC. : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 96. QIAGEN: KEY EXECUTIVES
- TABLE 97. QIAGEN: COMPANY SNAPSHOT
- TABLE 98. QIAGEN: OPERATING SEGMENTS
- TABLE 99. QIAGEN: PRODUCT PORTFOLIO
- TABLE 100. QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 101. MINERVA BIOLABS GMBH: KEY EXECUTIVES
- TABLE 102. MINERVA BIOLABS GMBH: COMPANY SNAPSHOT
- TABLE 103. MINERVA BIOLABS GMBH: OPERATING SEGMENTS
- TABLE 104. MINERVA BIOLABS GMBH: PRODUCT PORTFOLIO
- TABLE 105. MINERVA BIOLABS GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 106. ACON LABORATORIES, INC.: KEY EXECUTIVES
- TABLE 107. ACON LABORATORIES, INC.: COMPANY SNAPSHOT
- TABLE 108. ACON LABORATORIES, INC.: OPERATING SEGMENTS
- TABLE 109. ACON LABORATORIES, INC.: PRODUCT PORTFOLIO
- TABLE 110. ACON LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 111. BIO-RAD LABORATORIES, INC.: KEY EXECUTIVES
- TABLE 112. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
- TABLE 113. BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS
- TABLE 114. BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
- TABLE 115. BIO-RAD LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 116. ABNOVA CORPORATION: KEY EXECUTIVES
- TABLE 117. ABNOVA CORPORATION: COMPANY SNAPSHOT
- TABLE 118. ABNOVA CORPORATION: OPERATING SEGMENTS
- TABLE 119. ABNOVA CORPORATION: PRODUCT PORTFOLIO
- TABLE 120. ABNOVA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 121. MERCK KGAA: KEY EXECUTIVES
- TABLE 122. MERCK KGAA: COMPANY SNAPSHOT
- TABLE 123. MERCK KGAA: OPERATING SEGMENTS
- TABLE 124. MERCK KGAA: PRODUCT PORTFOLIO
- TABLE 125. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 126. PROMEGA CORPORATION: KEY EXECUTIVES
- TABLE 127. PROMEGA CORPORATION: COMPANY SNAPSHOT
- TABLE 128. PROMEGA CORPORATION: OPERATING SEGMENTS
- TABLE 129. PROMEGA CORPORATION: PRODUCT PORTFOLIO
- TABLE 130. PROMEGA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 131. F. HOFFMANN-LA ROCHE LTD: KEY EXECUTIVES
- TABLE 132. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
- TABLE 133. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
- TABLE 134. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
- TABLE 135. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 136. TECAN TRADING AG: KEY EXECUTIVES
- TABLE 137. TECAN TRADING AG: COMPANY SNAPSHOT
- TABLE 138. TECAN TRADING AG: OPERATING SEGMENTS
- TABLE 139. TECAN TRADING AG: PRODUCT PORTFOLIO
- TABLE 140. TECAN TRADING AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALDNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET
- FIGURE 10. GLOBAL DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET SEGMENTATION, BY PRODUCT
- FIGURE 11. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. GLOBAL DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET SEGMENTATION, BY APPLICATION
- FIGURE 14. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR PCR, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR NGS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR CLONING, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR MICROARRAY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR BLOTTING TECHNIQUES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. GLOBAL DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET SEGMENTATION, BY END USER
- FIGURE 21. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR CLINICAL DIAGNOSTIC AND FORENSIC LABORATORIES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR RESEARCH ACADEMICS AND INSTITUTIONS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 24. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 25. DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 30. COMPETITIVE DASHBOARD
- FIGURE 31. COMPETITIVE HEATMAP: DNA/RNA SAMPLE EXTRACTION AND ISOLATION MARKET
- FIGURE 32. TOP PLAYER POSITIONING, 2023
- FIGURE 33. THERMO FISHER SCIENTIFIC INC. : NET SALES, 2021-2023 ($BILLION)
- FIGURE 34. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. QIAGEN: NET SALES, 2021-2023 ($BILLION)
- FIGURE 37. QIAGEN: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. QIAGEN: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. MINERVA BIOLABS GMBH: NET SALES, 2021-2023 ($BILLION)
- FIGURE 40. MINERVA BIOLABS GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. MINERVA BIOLABS GMBH: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. ACON LABORATORIES, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 43. ACON LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. ACON LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. BIO-RAD LABORATORIES, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 46. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. ABNOVA CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 49. ABNOVA CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. ABNOVA CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 51. MERCK KGAA: NET SALES, 2021-2023 ($BILLION)
- FIGURE 52. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 53. MERCK KGAA: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 54. PROMEGA CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 55. PROMEGA CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 56. PROMEGA CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 57. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2021-2023 ($BILLION)
- FIGURE 58. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 59. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 60. TECAN TRADING AG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 61. TECAN TRADING AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 62. TECAN TRADING AG: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook